aniline has been researched along with Neoplasms in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (56.25) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Barrabés, S; Carrión, MC; Castañeda, G; Cuevas, JV; Durá, G; Fernández-Aroca, DM; Jalón, FA; Leal, J; Manzano, BR; Martínez, MA; Massaguer, A; Rodríguez, AM; Ruiz-Hidalgo, MJ; Sánchez-Prieto, R; Santos, L | 1 |
| Bai, YX; Qin, QP; Tan, MX; Wang, SL; Zou, BQ | 1 |
| Ariga, K; Hill, JP; Hishita, S; Ishihara, S; Izawa, H; Ji, Q; Kawakami, K; Kosaki, Y; Krishnan, V; Shiratori, S; Sumita, M; Tateyama, Y; Vinu, A; Yamauchi, Y | 1 |
| Chandrasekara Reddy, G; Chandregowda, V; Kush, AK | 1 |
| Berger, DM; Chaudhary, I; Collins, K; Dutia, M; Feldberg, L; Floyd, MB; Kim, S; Mallon, R; Powell, D; Torres, N; Wojciechowicz, D | 1 |
| TEMKIN, IS | 1 |
| DIOGUARDI, N | 1 |
| KAWAI, H | 1 |
| KOROSTELEVA, TA | 1 |
| WERTH, G | 1 |
| LIPKIN, IL | 1 |
| BAUER, KH | 1 |
| DRUCKREY, H | 2 |
| Ballard, P; Barlaam, BC; Bradbury, RH; Dishington, A; Hennequin, LF; Hickinson, DM; Hollingsworth, IM; Kettle, JG; Klinowska, T; Ogilvie, DJ; Pearson, SE; Scott, JS; Suleman, A; Whittaker, R; Williams, EJ; Wood, R; Wright, L | 1 |
1 review(s) available for aniline and Neoplasms
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
15 other study(ies) available for aniline and Neoplasms
| Article | Year |
|---|---|
Effect of the aniline fragment in Pt(II) and Pt(IV) complexes as anti-proliferative agents. Standard reduction potential as a more reliable parameter for Pt(IV) compounds than peak reduction potential.
Topics: A549 Cells; Aniline Compounds; Antineoplastic Agents; Apoptosis; Cell Proliferation; HCT116 Cells; Humans; MCF-7 Cells; Neoplasms; Organoplatinum Compounds; Platinum; Prodrugs | 2021 |
Synthesis, Characterization, and Cytotoxicity of the Cobalt (III) Complex with N,N-Diethyl-4-(2,2':6',2''-terpyridin-4'-yl)aniline.
Topics: Aniline Compounds; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cobalt; Coordination Complexes; Drug Screening Assays, Antitumor; G1 Phase Cell Cycle Checkpoints; Humans; Membrane Potentials; Mitochondria; Models, Molecular; Neoplasms | 2018 |
Nanoporous carbon sensor with cage-in-fiber structure: highly selective aniline adsorbent toward cancer risk management.
Topics: Adsorption; Aniline Compounds; Biosensing Techniques; Carbon; Humans; Nanoparticles; Neoplasms; Porosity; Quartz | 2013 |
Synthesis and in vitro antitumor activities of novel 4-anilinoquinazoline derivatives.
Topics: Aniline Compounds; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Design; ErbB Receptors; Gefitinib; Humans; Models, Molecular; Neoplasms; Phosphotransferases; Protein Structure, Tertiary; Quinazolines | 2009 |
4-Anilino-7-alkenylquinoline-3-carbonitriles as potent MEK1 kinase inhibitors.
Topics: Alkenes; Aniline Compounds; Animals; Cell Line, Tumor; Enzyme Activation; Humans; Inhibitory Concentration 50; Isoquinolines; MAP Kinase Kinase 1; Mice; Mice, Nude; Molecular Structure; Neoplasms; Nitriles; Protein Kinase Inhibitors; Structure-Activity Relationship; Substrate Specificity; Xenograft Model Antitumor Assays | 2008 |
[Pathogenesis of occupational (aniline) tumors of the bladder].
Topics: Aniline Compounds; Coloring Agents; Humans; Industry; Neoplasms; Occupational Diseases; Occupations; Urinary Bladder Neoplasms | 1948 |
[Tumors of the urinary bladder and carcinogens].
Topics: Aniline Compounds; Carcinogens; Coloring Agents; Neoplasms; Urinary Bladder Neoplasms | 1953 |
[An autopsy case of aniline cancer].
Topics: Aniline Compounds; Autopsy; Coloring Agents; Neoplasms | 1953 |
[Precipitation method in detection of specific antigens created after orthoaminotoluol administration].
Topics: Aniline Compounds; Antibodies; Antigens; Coloring Agents; Immune System Phenomena; Neoplasms | 1956 |
[Production of tumors and disturbances in heredity pattern by experimental tissue anoxia].
Topics: Aniline Compounds; Animals; Coloring Agents; Heredity; Metabolism; Neoplasms; Neoplasms, Experimental | 1958 |
PREVENTION OF OCCUPATIONAL CANCER OF THE URINARY BLADDER IN WORKERS IN ANILINE DYES INDUSTRY IN THE U.S.S.R.
Topics: Aniline Compounds; Carcinogens; Coloring Agents; Humans; Industry; Neoplasms; Occupational Diseases; Preventive Medicine; Toxicology; United States; Urinary Bladder Neoplasms; USSR | 1963 |
[Chemistry and cancer; on aniline cancer (L. Rehn)].
Topics: Aniline Compounds; Neoplasms | 1950 |
[Experimental cancer provoked by aniline and aniline-derivatives].
Topics: Aniline Compounds; Biochemical Phenomena; Biochemistry; Humans; Neoplasms | 1950 |
[Pharmacology of cancerogenic substances; experiments with aniline].
Topics: Aniline Compounds; Humans; Neoplasms | 1950 |
Neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.
Topics: Administration, Oral; Aniline Compounds; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Dogs; Drug Synergism; Mice; Molecular Structure; Neoplasms; Quinazolines; Rats; Receptor, ErbB-2; Triazoles; Xenograft Model Antitumor Assays | 2007 |